BUILD IT.
For scientists, technical teams, and founders turning promising science into a real product.
Learn the path →It is rarely a straight line. Swerve helps scientists, companies, executives, boards, and investors recognize the decisions that change trajectory and find the better path forward.
Evidence changes the trajectory. Judgment determines what comes next.
The underlying challenge is the same: understand where you are, what changed, what matters, and what should happen next.
For scientists, technical teams, and founders turning promising science into a real product.
Learn the path →For executives and boards making consequential product, development, regulatory, and portfolio decisions.
Clarify the decision →For investors determining whether scientific opportunity can become a viable regulated product and business.
Pressure-test the path →Swerve combines senior advisory judgment with applied decision labs, interactive tools, free learning, original analysis, and investor intelligence. Some offerings generate revenue. Others build authority, visibility, and access. All of them reinforce the same promise.
Scientific, clinical, regulatory, quality, product-development, portfolio, executive, board, and investor support.
Explore Advisory →Focused working sessions that turn a consequential question into a defined path forward.
Enter the Labs →Find blind spots, test assumptions, understand consequences, and determine what should happen next.
Explore Tools →Live and on-demand conversations for scientists, leaders, boards, and investors.
See the series →What changed. Why it matters. Where to go next.
Join the list →Articles, models, frameworks, playbooks, and practical analysis from Swerve Molecular.
Read Insights →The moment may look different every time. The decision logic does not.
Separate facts, assumptions, interpretations, and unknowns. Identify what actually changes the decision.
Determine whether the original path still makes sense, where risk is accumulating, and where opportunity has opened.
Translate insight into a clear next move with evidence, ownership, and consequences.
A concise weekly decision brief for people building, leading, and funding regulated life-science innovation.
Join The Weekly SwerveWhat the change means at the bench and product level.
What the change means for development and organizational decisions.
What the change means for risk, capital, and probability of success.
Sometimes it is the opportunity.
Let's find it